Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11
Background: The role of estrogen in liver cancer cells has attracted attention, but its specific actions and underlying mechanisms remain unclear. Methods: Flow CytoMetry and Western blotting were used to investigate the mechanism of HOXA11-AS and estrogen in promoting apoptosis of hepatocellular ca...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325001354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849309927792705536 |
|---|---|
| author | Pincheng Zhou Fengze Sun Peixu Lin Yan Yan Jiayao Liu Yang Zhou Ting He Pengcheng Liu Jie Wang Huanhuan Sun Haiqing Ma |
| author_facet | Pincheng Zhou Fengze Sun Peixu Lin Yan Yan Jiayao Liu Yang Zhou Ting He Pengcheng Liu Jie Wang Huanhuan Sun Haiqing Ma |
| author_sort | Pincheng Zhou |
| collection | DOAJ |
| description | Background: The role of estrogen in liver cancer cells has attracted attention, but its specific actions and underlying mechanisms remain unclear. Methods: Flow CytoMetry and Western blotting were used to investigate the mechanism of HOXA11-AS and estrogen in promoting apoptosis of hepatocellular carcinoma (HCC). In vivo subcutaneous tumorigenesis assays were uesd to confirm the regulatory role of HOXA11-AS in HCC progression. Through immunohistochemistry, the correlation between HOXA11 expression and the prognosis of patients with HCC was explored. Results: Estrogen was found to promote apoptosis in HCC cells, dependent on HOXA11-AS. HOXA11 and HOXA11-AS are upregulated in HCC tissues. Downregulation of HOXA11-AS and HOXA11 significantly inhibited cell proliferation, migration, and invasion in HCC. HOXA11-AS forms an RNA duplex with HOXA11, preventing RNase degradation. In HCC patients, high HOXA11 expression was significantly associated with lower overall survival (OS) (p=0.001) and disease-free survival (DFS) (p=0.002). High HOXA11 expression was also significantly correlated with recurrence (p<0.001), major vascular invasion (p=0.002) and increased tumor volume (p=0.007). Estrogen activated the c-met/AKT/mTOR pathway in the HCC cell line. Conclusion: Estrogen and its related proteins have therapeutic effects in HCC and may be new potential therapeutic targets. |
| format | Article |
| id | doaj-art-ed11e641e1424f1e95b81d51273005b0 |
| institution | Kabale University |
| issn | 1936-5233 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Translational Oncology |
| spelling | doaj-art-ed11e641e1424f1e95b81d51273005b02025-08-20T03:53:56ZengElsevierTranslational Oncology1936-52332025-07-015710240410.1016/j.tranon.2025.102404Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11Pincheng Zhou0Fengze Sun1Peixu Lin2Yan Yan3Jiayao Liu4Yang Zhou5Ting He6Pengcheng Liu7Jie Wang8Huanhuan Sun9Haiqing Ma10School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China; Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaZhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University),Zhuhai, Guangdong 519000, China; The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, ChinaGuangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaThe Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, ChinaSchool of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China; Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaSchool of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China; Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaGuangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaGuangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaGuangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, ChinaGuangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, China; Corresponding authors.School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China; Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University,Guangzhou, Guangdong 510006, China; Heyuan Hospital of Guangdong Provincial People’s Hospital, Heyuan People’s Hospital, Heyuan, Guangdong 517000, China; Corresponding authors.Background: The role of estrogen in liver cancer cells has attracted attention, but its specific actions and underlying mechanisms remain unclear. Methods: Flow CytoMetry and Western blotting were used to investigate the mechanism of HOXA11-AS and estrogen in promoting apoptosis of hepatocellular carcinoma (HCC). In vivo subcutaneous tumorigenesis assays were uesd to confirm the regulatory role of HOXA11-AS in HCC progression. Through immunohistochemistry, the correlation between HOXA11 expression and the prognosis of patients with HCC was explored. Results: Estrogen was found to promote apoptosis in HCC cells, dependent on HOXA11-AS. HOXA11 and HOXA11-AS are upregulated in HCC tissues. Downregulation of HOXA11-AS and HOXA11 significantly inhibited cell proliferation, migration, and invasion in HCC. HOXA11-AS forms an RNA duplex with HOXA11, preventing RNase degradation. In HCC patients, high HOXA11 expression was significantly associated with lower overall survival (OS) (p=0.001) and disease-free survival (DFS) (p=0.002). High HOXA11 expression was also significantly correlated with recurrence (p<0.001), major vascular invasion (p=0.002) and increased tumor volume (p=0.007). Estrogen activated the c-met/AKT/mTOR pathway in the HCC cell line. Conclusion: Estrogen and its related proteins have therapeutic effects in HCC and may be new potential therapeutic targets.http://www.sciencedirect.com/science/article/pii/S1936523325001354EstrogenHOXA11HOXA11-ASHepatocellular carcinoma |
| spellingShingle | Pincheng Zhou Fengze Sun Peixu Lin Yan Yan Jiayao Liu Yang Zhou Ting He Pengcheng Liu Jie Wang Huanhuan Sun Haiqing Ma Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11 Translational Oncology Estrogen HOXA11 HOXA11-AS Hepatocellular carcinoma |
| title | Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11 |
| title_full | Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11 |
| title_fullStr | Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11 |
| title_full_unstemmed | Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11 |
| title_short | Estrogen inhibits hepatocellular carcinoma progression dependent on HOXA11-AS/HOXA11 |
| title_sort | estrogen inhibits hepatocellular carcinoma progression dependent on hoxa11 as hoxa11 |
| topic | Estrogen HOXA11 HOXA11-AS Hepatocellular carcinoma |
| url | http://www.sciencedirect.com/science/article/pii/S1936523325001354 |
| work_keys_str_mv | AT pinchengzhou estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT fengzesun estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT peixulin estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT yanyan estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT jiayaoliu estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT yangzhou estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT tinghe estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT pengchengliu estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT jiewang estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT huanhuansun estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 AT haiqingma estrogeninhibitshepatocellularcarcinomaprogressiondependentonhoxa11ashoxa11 |